Table 3 |
||||||||
|
Large-scale comparison between KEGG spider and GENECODIS |
||||||||
|
Input proteins/genes |
GENECODIS |
KEGG spider |
||||||
|
|
|
|
||||||
|
Paper |
Table |
All |
KEGG |
k |
max |
Model |
n |
P-value |
|
|
||||||||
|
Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma [40] |
Table 1: proteins found to be differentially expressed between matched normal and RCC primary lines |
62 |
23 |
5 |
10 |
D3 |
22 |
<0.01 |
|
Proteomic analysis of anaplastic lymphoma cell lines: identification of potential tumour markers [41] |
Table 2: proteins overexpressed in FE-PD cells compared to SU-DHL-1 cells |
41 |
13 |
3 |
3 |
D2 |
12 |
0.015 |
|
Differential expression profiling of human pancreatic adenocarcinoma and healthy pancreatic tissue [42] |
Table 3: proteins at higher levels in normal pancreas compared to pancreatic cancer |
40 |
12 |
2 |
5 |
D3 |
12 |
0.015 |
|
Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma [43] |
Table 1: differentially expressed proteins in human ovarian cancer cells |
36 |
17 |
3 |
4 |
D2 |
13 |
0.025 |
|
Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma [44] |
Table 3: differentially expressed proteins in RCC patients |
91 |
36 |
12 |
14 |
D2 |
33 |
<0.001 |
|
Protein profile changes in the human breast cancer cell line MCF-7 in response to SEL1L [45] |
Table 4: MCF7-SEL1L differentially expressed genes identified by microarray analysis |
60 |
9 |
1 |
4 |
D2 |
7 |
0.03 |
|
Protein dysregulation in mouse hippocampus polytransgenic for chromosome 21 structures in the Down syndrome critical region [46] |
Table 2: list of proteins dysregulated in hippocampus of polytransgenic micea |
42 |
14 |
2 |
5 |
D2 |
12 |
0.015 |
|
Differential expression of proteins in response to ceramide-mediated stress signal in colon cancer cells by 2-D gel electrophoresis and MALDI-TOF-MS [47] |
Table 1: list of identified proteins on HCT116 2-DE gels |
82 |
16 |
2 |
4 |
D3 |
15 |
0.02 |
|
Subcellular proteome analysis of camptothecin analogue NSC606985-treated acute myeloid leukemic cells [48] |
Table 2: functional classifications of the deregulated proteins in NSC606985-induced apoptotic NB4 Cellsa |
88 |
15 |
1 |
5 |
D3 |
15 |
<0.001 |
|
Proteome analysis of responses to ascochlorin in a human osteosarcoma cell line by 2-D gel electrophoresis and MALDI-TOF MS [49] |
Table 2: differentially expressed proteins in ascochlorin-treated U2OS cells |
87 |
13 |
3 |
5 |
D2 |
12 |
<0.001 |
|
Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells [50] |
Table 1: summary of differentially expressed proteins and their functional classifications |
227 |
59 |
11 |
9 |
D3 |
54 |
<0.001 |
|
Proteomic analysis of the resistance to aplidin in human cancer cells [51] |
Table 1: differentially expressed proteins between resistant and wild-type HeLa cells identified in the membrane fraction |
26 |
8 |
5 |
3 |
D2 |
6 |
0.02 |
|
Proteomic analysis of the resistance to aplidin in human cancer cells [51] |
Table 2: differentially expressed proteins between resistant and wild-type HeLa cells identified in the cytosolic fraction |
37 |
11 |
5 |
7 |
D2 |
11 |
0.015 |
|
Identification of specific protein markers in microdissected hepatocellular carcinoma |
Table 2: identified proteins from HCC and nontumorous liver tissue by in-gel digestion and SELDI-MS |
51 |
20 |
8 |
4 |
D2 |
17 |
0.015 |
|
Comparison of membrane-associated proteins in human cholangiocarcinoma and hepatocellular carcinoma cell lines [52] |
Table 1: list of proteins from the membrane fraction of HuCCA-1 and HCC-S102 cell lines which show up-regulated expression |
56 |
11 |
2 |
5 |
D3 |
11 |
<0.001 |
|
Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis [53] |
Table 1: proteins differentially expressed in tumorous LM-hepatocytes and total homogenates samples identified PMF |
43 |
20 |
0 |
0 |
D3 |
18 |
0.04 |
|
Proteome alterations induced in human white blood cells by consumption of Brussels sprouts: results of a pilot intervention study [54] |
Table 1: protein alterations induced by a controlled dietary intervention with Brussels sprouts in human primary white blood cells |
44 |
17 |
2 |
4 |
D2 |
12 |
<0.05 |
|
|
||||||||
|
The 'Paper' column reports the title of the paper that reported a list of differentially expressed proteins/genes related to different diseases or treated/untreated cell states. The 'Table' column reports the table number and legend from the paper. The 'Input proteins/genes' section reports the total number of proteins/genes (All) and the number (KEGG) that mapped to KEGG pathways. The 'GENECODIS' section reports results provided by GENECODIS; the 'k' column reports the number of pathways found to be enriched (p-value < 0.05); the 'max' column reports the number of input genes covered by the largest pathway. The 'KEGG spider' section reports results provided by KEGG spider; the 'Model' column specifies the most significant model (D2 or D3); the 'n' column reports the number of input proteins/genes covered by the model; the p-value column reports significance estimated by a Monte Carlo simulation procedure. |
||||||||
|
Antonov et al. Genome Biology 2008 9:R179 doi:10.1186/gb-2008-9-12-r179 |
||||||||